In addition to evaluating the EGFR-TKI treatment efficacy and the emergence of resistance mechanisms, the use of the ddPCR method for EGFR mutation detection is proven to be valuable in predicting tumor metastasis and patient outcomes. Here, EGFR is linked to neoplasm.